Title:
【発明の名称】アリールおよびヘテロアリールアルコキシナフタレン誘導体
Document Type and Number:
Japanese Patent JP3012338
Kind Code:
B2
Abstract:
Compounds of the formula wherein R1, R2, R4, R23, R24, R25 and R26 are defined as in the specification. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and antagonists.
Inventors:
Chenard, Badland, Elle.
Desai, Kitsho, A.
Howard, Harry, Earl., Junior.
McCall, John, Yi.
Schenk, Kevin, Dee.
Desai, Kitsho, A.
Howard, Harry, Earl., Junior.
McCall, John, Yi.
Schenk, Kevin, Dee.
Application Number:
JP50296196A
Publication Date:
February 21, 2000
Filing Date:
May 18, 1995
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
A61K31/4402; A61K31/4418; A61K31/4427; A61K31/4433; A61K31/445; A61K31/451; A61K31/495; A61K31/496; A61K31/50; A61K31/505; A61K31/54; A61P9/12; A61P25/00; A61P25/24; A61P25/26; A61P43/00; C07D207/333; C07D209/34; C07D211/22; C07D211/24; C07D211/26; C07D213/30; C07D213/64; C07D213/85; C07D295/14; C07D215/14; C07D237/14; C07D239/34; C07D239/42; C07D257/04; C07D261/08; C07D261/20; C07D263/32; C07D263/56; C07D263/58; C07D271/06; C07D271/10; C07D271/107; C07D275/02; C07D277/24; C07D277/64; C07D295/155; C07D333/28; C07D401/12; C07D409/12; C07D413/04; C07D413/12; C07D413/14; C07D417/12; C07D471/04; (IPC1-7): C07D207/333; C07D209/34; C07D211/22; C07D211/24; C07D211/26; C07D213/30; C07D215/14; C07D257/04; C07D261/08; C07D261/20; C07D263/32; C07D263/56; C07D263/58; C07D271/06; C07D271/10; C07D275/02; C07D277/24; C07D295/14; C07D401/12; C07D409/12; C07D413/12; C07D413/14; C07D417/12; C07D471/04
Domestic Patent References:
| JPH03192220A | 1991-08-22 | |||
| JPH02199425A | 1990-08-07 |
Attorney, Agent or Firm:
Hiroshi Kobayashi